Physician
Sankari, Susan
Sankari, Susan was paid $1.21M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoSANKARI, SUSAN
LISLE, IL 60532
LISLE, IL 60532
33aNPI1306984216assigned 02/02/2007
33bProvider typePediatrics Physician
28Total paid$1.21M
24GClaims36,491
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#116 of 1,805
Median peer was paid$55K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,272 | $101K | |
| 2019 | 4,624 | $136K | |
| 2020 | 5,403 | $154K | |
| 2021 | 6,035 | $185K | |
| 2022 | 5,349 | $203K | |
| 2023 | 4,970 | $186K | |
| 2024incomplete | 6,838 | $247K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 10,099 | 7,101 | $491K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 2,584 | 2,145 | $206K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 2,190 | 1,948 | $164K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 968 | 836 | $72K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.4% | 786 | 681 | $54K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.7% | 2,152 | 1,782 | $33K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.5% | 596 | 550 | $31K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 255 | 215 | $20K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 206 | 173 | $16K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 576 | 556 | $16K |
| 36416 | 1.2% | 3,530 | 3,049 | $14K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 412 | 365 | $12K |
33 more codes
| 90670 | <1% | 740 | $11K | |
| 85018 | <1% | 3,864 | $9K | |
| 81002 | <1% | 2,921 | $8K | |
| 99000 | <1% | 427 | $7K | |
| 90686 | <1% | 579 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 435 | $5K |
| 96127 | <1% | 369 | $5K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 271 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 192 | $5K |
| 90633 | <1% | 268 | $3K | |
| 90648 | <1% | 336 | $3K | |
| 92650 | <1% | 132 | $2K | |
| 90685 | <1% | 229 | $2K | |
| 90656 | <1% | 114 | $2K | |
| 90658 | <1% | 131 | $2K | |
| 92567 | <1% | 115 | $1K | |
| 90734 | <1% | 35 | $863.90 | |
| 90707 | <1% | 42 | $644.00 | |
| 90660 | <1% | 38 | $634.98 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $459.29 |
| 90716 | <1% | 29 | $437.80 | |
| 94760 | <1% | 159 | $430.04 | |
| 90619 | <1% | 19 | $317.49 | |
| 90715 | <1% | 18 | $300.78 | |
| 96160 | <1% | 19 | $277.40 | |
| 90698 | <1% | 45 | $275.20 | |
| 90700 | <1% | 30 | $192.00 | |
| 90681 | <1% | 24 | $153.60 | |
| 94150 | <1% | 16 | $121.60 | |
| 90649 | <1% | 18 | $115.20 | |
| 90723 | <1% | 12 | $76.80 | |
| 99072 | 0% | 421 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 75 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.